Karyopharm Therapeutics Inc. (KPTI): Price and Financial Metrics
Karyopharm Therapeutics Inc. (KPTI)
Today's Latest Price: $15.33 USD
Updated Jan 20 6:55pm
Add KPTI to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 239 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
KPTI Stock Summary
- KPTI's price/sales ratio is 12.39; that's higher than the P/S ratio of 85.62% of US stocks.
- As for revenue growth, note that KPTI's revenue has grown 295.95% over the past 12 months; that beats the revenue growth of 97.7% of US companies in our set.
- Karyopharm Therapeutics Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -18%, greater than the shareholder yield of only 14.31% of stocks in our set.
- Stocks that are quantitatively similar to KPTI, based on their financial statements, market capitalization, and price volatility, are FBIO, PROF, QUIK, ATNX, and RDUS.
- Visit KPTI's SEC page to see the company's official filings. To visit the company's web site, go to www.karyopharm.com.
KPTI Stock Price Chart Interactive Chart >
KPTI Price/Volume Stats
| Current price | $15.33 | 52-week high | $29.61 |
| Prev. close | $15.08 | 52-week low | $13.39 |
| Day low | $14.96 | Volume | 2,257,200 |
| Day high | $15.42 | Avg. volume | 2,538,383 |
| 50-day MA | $15.77 | Dividend yield | N/A |
| 200-day MA | $17.07 | Market Cap | 1.13B |
Karyopharm Therapeutics Inc. (KPTI) Company Bio
Karyopharm Therapeutics is a clinical-stage pharmaceutical company focused on the discovery and development of drugs directed against nuclear transport targets for the treatment of cancer and other major diseases. The company was founded in 2008 and is based in in Newton, Massachusetts.
Loading social stream, please wait...